Skip to main content
Top
Published in: BMC Cancer 1/2010

Open Access 01-12-2010 | Research article

Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion

Authors: Deshui Jia, Mingxia Yan, Xiaomin Wang, Xiangfang Hao, Linhui Liang, Lei Liu, Hanwei Kong, Xianghuo He, Jinjun Li, Ming Yao

Published in: BMC Cancer | Issue 1/2010

Login to get access

Abstract

Background

The formation of metastasis is the most common cause of death in patients with lung cancer. A major implement to understand the molecular mechanisms involved in lung cancer metastasis has been the lack of suitable models to address it. In this study, we aimed at establishing a highly metastatic model of human lung cancer and characterizing its metastatic properties and underlying mechanisms.

Methods

The human lung adeno-carcinoma SPC-A-1 cell line was used as parental cells for developing of highly metastatic cells by in vivo selection in NOD/SCID mice. After three rounds of selection, a new SPC-A-1sci cell line was established from pulmonary metastatic lesions. Subsequently, the metastatic properties of this cell line were analyzed, including optical imaging of in vivo metastasis, immunofluorescence and immunohistochemical analysis of several epithelial mesenchymal transition (EMT) makers and trans-well migration and invasion assays. Finally, the functional roles of fibronectin in the invasive and metastatic potentials of SPC-A-1sci cells were determined by shRNA analysis.

Results

A spontaneously pulmonary metastatic model of human lung adeno-carcinoma was established in NOD/SCID mice, from which a new lung cancer cell line, designated SPC-A-1sci, was isolated. Initially, the highly metastatic behavior of this cell line was validated by optical imaging in mice models. Further analyses showed that this cell line exhibit phenotypic and molecular alterations consistent with EMT. Compared with its parent cell line SPC-A-1, SPC-A-1sci was more aggressive in vitro, including increased potentials for cell spreading, migration and invasion. Importantly, fibronectin, a mesenchymal maker of EMT, was found to be highly expressed in SPC-A-1sci cells and down-regulation of it can decrease the in vitro and in vivo metastatic abilities of this cell line.

Conclusions

We have successfully established a new human lung cancer cell line with highly metastatic potentials, which is subject to EMT and possibly mediated by increased fibronectin expression. This cell line and its reproducible s.c. mouse model can further be used to identify underlying mechanisms of lung cancer metastasis.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Lozano G, et al: Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS ONE. 2009, 4 (4): e5401-10.1371/journal.pone.0005401.CrossRefPubMedPubMedCentral Gibbons DL, Lin W, Creighton CJ, Zheng S, Berel D, Yang Y, Raso MG, Liu DD, Lozano G, et al: Expression signatures of metastatic capacity in a genetic mouse model of lung adenocarcinoma. PLoS ONE. 2009, 4 (4): e5401-10.1371/journal.pone.0005401.CrossRefPubMedPubMedCentral
2.
go back to reference Tanaka E, Yamashita J, Hayashi N, Kato S, Kondo K, Ogawa M: A pulmonary metastatic model of human non-small cell lung carcinoma cells that produce a neutrophil elastase-like molecule in severe combined immunodeficiency mice. Chest. 2003, 123 (4): 1248-1253. 10.1378/chest.123.4.1248.CrossRefPubMed Tanaka E, Yamashita J, Hayashi N, Kato S, Kondo K, Ogawa M: A pulmonary metastatic model of human non-small cell lung carcinoma cells that produce a neutrophil elastase-like molecule in severe combined immunodeficiency mice. Chest. 2003, 123 (4): 1248-1253. 10.1378/chest.123.4.1248.CrossRefPubMed
3.
go back to reference Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000, 406 (6795): 532-535. 10.1038/35020106.CrossRefPubMed Clark EA, Golub TR, Lander ES, Hynes RO: Genomic analysis of metastasis reveals an essential role for RhoC. Nature. 2000, 406 (6795): 532-535. 10.1038/35020106.CrossRefPubMed
4.
go back to reference Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature. 2005, 436 (7050): 518-524. 10.1038/nature03799.CrossRefPubMedPubMedCentral Minn AJ, Gupta GP, Siegel PM, Bos PD, Shu W, Giri DD, Viale A, Olshen AB, Gerald WL, Massague J: Genes that mediate breast cancer metastasis to lung. Nature. 2005, 436 (7050): 518-524. 10.1038/nature03799.CrossRefPubMedPubMedCentral
5.
go back to reference Guarino M, Rubino B, Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007, 39 (3): 305-318. 10.1080/00313020701329914.CrossRefPubMed Guarino M, Rubino B, Ballabio G: The role of epithelial-mesenchymal transition in cancer pathology. Pathology. 2007, 39 (3): 305-318. 10.1080/00313020701329914.CrossRefPubMed
6.
go back to reference Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C: Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol. 2009, 22 (5): 668-678. 10.1038/modpathol.2009.19.CrossRefPubMedPubMedCentral Prudkin L, Liu DD, Ozburn NC, Sun M, Behrens C, Tang X, Brown KC, Bekele BN, Moran C: Epithelial-to-mesenchymal transition in the development and progression of adenocarcinoma and squamous cell carcinoma of the lung. Mod Pathol. 2009, 22 (5): 668-678. 10.1038/modpathol.2009.19.CrossRefPubMedPubMedCentral
7.
go back to reference Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY: Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cellular signalling. 2009, 21 (5): 704-711. 10.1016/j.cellsig.2009.01.008.CrossRefPubMed Chou TY, Chen WC, Lee AC, Hung SM, Shih NY, Chen MY: Clusterin silencing in human lung adenocarcinoma cells induces a mesenchymal-to-epithelial transition through modulating the ERK/Slug pathway. Cellular signalling. 2009, 21 (5): 704-711. 10.1016/j.cellsig.2009.01.008.CrossRefPubMed
8.
go back to reference Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nature reviews. 2009, 9 (4): 239-252. 10.1038/nrc2618.PubMed Joyce JA, Pollard JW: Microenvironmental regulation of metastasis. Nature reviews. 2009, 9 (4): 239-252. 10.1038/nrc2618.PubMed
9.
go back to reference Hu M, Carles-Kinch KL, Zelinski DP, Kinch MS: EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. Mol Cancer Res. 2004, 2 (10): 533-540.PubMed Hu M, Carles-Kinch KL, Zelinski DP, Kinch MS: EphA2 induction of fibronectin creates a permissive microenvironment for malignant cells. Mol Cancer Res. 2004, 2 (10): 533-540.PubMed
10.
go back to reference Zheng Y, Ritzenthaler JD, Roman J, Han S: Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. American journal of respiratory cell and molecular biology. 2007, 37 (6): 681-690. 10.1165/rcmb.2007-0051OC.CrossRefPubMed Zheng Y, Ritzenthaler JD, Roman J, Han S: Nicotine stimulates human lung cancer cell growth by inducing fibronectin expression. American journal of respiratory cell and molecular biology. 2007, 37 (6): 681-690. 10.1165/rcmb.2007-0051OC.CrossRefPubMed
11.
go back to reference Ritzenthaler JD, Han S, Roman J: Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Molecular bioSystems. 2008, 4 (12): 1160-1169. 10.1039/b800533h.CrossRefPubMed Ritzenthaler JD, Han S, Roman J: Stimulation of lung carcinoma cell growth by fibronectin-integrin signalling. Molecular bioSystems. 2008, 4 (12): 1160-1169. 10.1039/b800533h.CrossRefPubMed
12.
go back to reference Han S, Khuri FR, Roman J: Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer research. 2006, 66 (1): 315-323. 10.1158/0008-5472.CAN-05-2367.CrossRefPubMed Han S, Khuri FR, Roman J: Fibronectin stimulates non-small cell lung carcinoma cell growth through activation of Akt/mammalian target of rapamycin/S6 kinase and inactivation of LKB1/AMP-activated protein kinase signal pathways. Cancer research. 2006, 66 (1): 315-323. 10.1158/0008-5472.CAN-05-2367.CrossRefPubMed
13.
go back to reference Han S, Ritzenthaler JD, Sitaraman SV, Roman J: Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. The Journal of biological chemistry. 2006, 281 (40): 29614-29624. 10.1074/jbc.M604013200.CrossRefPubMed Han S, Ritzenthaler JD, Sitaraman SV, Roman J: Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. The Journal of biological chemistry. 2006, 281 (40): 29614-29624. 10.1074/jbc.M604013200.CrossRefPubMed
14.
go back to reference Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY, et al: Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. British journal of cancer. 2009, 101 (2): 327-334. 10.1038/sj.bjc.6605154.CrossRefPubMedPubMedCentral Meng XN, Jin Y, Yu Y, Bai J, Liu GY, Zhu J, Zhao YZ, Wang Z, Chen F, Lee KY, et al: Characterisation of fibronectin-mediated FAK signalling pathways in lung cancer cell migration and invasion. British journal of cancer. 2009, 101 (2): 327-334. 10.1038/sj.bjc.6605154.CrossRefPubMedPubMedCentral
15.
go back to reference Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q: Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Journal of cancer research and clinical oncology. 2003, 129 (1): 43-51. 10.1007/s00432-003-0493-z.PubMed Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q: Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray. Journal of cancer research and clinical oncology. 2003, 129 (1): 43-51. 10.1007/s00432-003-0493-z.PubMed
16.
go back to reference Wu D, Chen X, Guo D, Hong Q, Fu B, Ding R, Yu L, Hou K, Feng Z, Zhang X, et al: Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. J Am Soc Nephrol. 2005, 16 (3): 646-657. 10.1681/ASN.2004060445.CrossRefPubMed Wu D, Chen X, Guo D, Hong Q, Fu B, Ding R, Yu L, Hou K, Feng Z, Zhang X, et al: Knockdown of fibronectin induces mitochondria-dependent apoptosis in rat mesangial cells. J Am Soc Nephrol. 2005, 16 (3): 646-657. 10.1681/ASN.2004060445.CrossRefPubMed
17.
go back to reference Caceres G, Zhu XY, Jiao JA, Zankina R, Aller A, Andreotti P: Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence. 2003, 18 (4): 218-223. 10.1002/bio.729.CrossRefPubMed Caceres G, Zhu XY, Jiao JA, Zankina R, Aller A, Andreotti P: Imaging of luciferase and GFP-transfected human tumours in nude mice. Luminescence. 2003, 18 (4): 218-223. 10.1002/bio.729.CrossRefPubMed
18.
go back to reference Ciana P, Brena A, Sparaciari P, Bonetti E, Di Lorenzo D, Maggi A: Estrogenic activities in rodent estrogen-free diets. Endocrinology. 2005, 146 (12): 5144-5150. 10.1210/en.2005-0660.CrossRefPubMed Ciana P, Brena A, Sparaciari P, Bonetti E, Di Lorenzo D, Maggi A: Estrogenic activities in rodent estrogen-free diets. Endocrinology. 2005, 146 (12): 5144-5150. 10.1210/en.2005-0660.CrossRefPubMed
19.
go back to reference Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumourigenicity. International journal of cancer. 2007, 120 (7): 1444-1450. 10.1002/ijc.22476.CrossRefPubMed Yin S, Li J, Hu C, Chen X, Yao M, Yan M, Jiang G, Ge C, Xie H, Wan D, et al: CD133 positive hepatocellular carcinoma cells possess high capacity for tumourigenicity. International journal of cancer. 2007, 120 (7): 1444-1450. 10.1002/ijc.22476.CrossRefPubMed
20.
go back to reference Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T: A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clinical & experimental metastasis. 2008, 25 (5): 517-529.CrossRef Takahashi M, Furihata M, Akimitsu N, Watanabe M, Kaul S, Yumoto N, Okada T: A highly bone marrow metastatic murine breast cancer model established through in vivo selection exhibits enhanced anchorage-independent growth and cell migration mediated by ICAM-1. Clinical & experimental metastasis. 2008, 25 (5): 517-529.CrossRef
21.
go back to reference Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP: CD24 expression causes the acquisition of multiple cellular properties associated with tumour growth and metastasis. Cancer research. 2005, 65: 10783-10793. 10.1158/0008-5472.CAN-05-0619.CrossRefPubMed Baumann P, Cremers N, Kroese F, Orend G, Chiquet-Ehrismann R, Uede T, Yagita H, Sleeman JP: CD24 expression causes the acquisition of multiple cellular properties associated with tumour growth and metastasis. Cancer research. 2005, 65: 10783-10793. 10.1158/0008-5472.CAN-05-0619.CrossRefPubMed
22.
go back to reference Munoz R, Man S, Shaked Y, Lee CR, Wong J, Francia G, Kerbel RS: Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer research. 2006, 66 (7): 3386-3391. 10.1158/0008-5472.CAN-05-4411.CrossRefPubMed Munoz R, Man S, Shaked Y, Lee CR, Wong J, Francia G, Kerbel RS: Highly efficacious nontoxic preclinical treatment for advanced metastatic breast cancer using combination oral UFT-cyclophosphamide metronomic chemotherapy. Cancer research. 2006, 66 (7): 3386-3391. 10.1158/0008-5472.CAN-05-4411.CrossRefPubMed
23.
go back to reference Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumour metastasis. Developmental cell. 2008, 14 (6): 818-829. 10.1016/j.devcel.2008.05.009.CrossRefPubMed Yang J, Weinberg RA: Epithelial-mesenchymal transition: at the crossroads of development and tumour metastasis. Developmental cell. 2008, 14 (6): 818-829. 10.1016/j.devcel.2008.05.009.CrossRefPubMed
24.
go back to reference Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed Thiery JP, Sleeman JP: Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol. 2006, 7 (2): 131-142. 10.1038/nrm1835.CrossRefPubMed
25.
go back to reference Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell. 2004, 117 (7): 927-939. 10.1016/j.cell.2004.06.006.CrossRefPubMed Yang J, Mani SA, Donaher JL, Ramaswamy S, Itzykson RA, Come C, Savagner P, Gitelman I, Richardson A, Weinberg RA: Twist, a master regulator of morphogenesis, plays an essential role in tumour metastasis. Cell. 2004, 117 (7): 927-939. 10.1016/j.cell.2004.06.006.CrossRefPubMed
26.
go back to reference Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer metastasis reviews. 1991, 10 (3): 229-243. 10.1007/BF00050794.CrossRefPubMed Fidler IJ: Orthotopic implantation of human colon carcinomas into nude mice provides a valuable model for the biology and therapy of metastasis. Cancer metastasis reviews. 1991, 10 (3): 229-243. 10.1007/BF00050794.CrossRefPubMed
27.
go back to reference Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR: c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumour model. Lung cancer (Amsterdam, Netherlands). 2008, 60 (3): 347-354.CrossRef Sekhon HS, London CA, Sekhon M, Iversen PL, Devi GR: c-MYC antisense phosphosphorodiamidate morpholino oligomer inhibits lung metastasis in a murine tumour model. Lung cancer (Amsterdam, Netherlands). 2008, 60 (3): 347-354.CrossRef
28.
go back to reference Fork MA, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HJ, Bullerdiek J, et al: Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC cancer. 2008, 8: 240-10.1186/1471-2407-8-240.CrossRefPubMedPubMedCentral Fork MA, Murua Escobar H, Soller JT, Sterenczak KA, Willenbrock S, Winkler S, Dorsch M, Reimann-Berg N, Hedrich HJ, Bullerdiek J, et al: Establishing an in vivo model of canine prostate carcinoma using the new cell line CT1258. BMC cancer. 2008, 8: 240-10.1186/1471-2407-8-240.CrossRefPubMedPubMedCentral
29.
go back to reference Cruz-Munoz W, Man S, Xu P, Kerbel RS: Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer research. 2008, 68 (12): 4500-4505. 10.1158/0008-5472.CAN-08-0041.CrossRefPubMed Cruz-Munoz W, Man S, Xu P, Kerbel RS: Development of a preclinical model of spontaneous human melanoma central nervous system metastasis. Cancer research. 2008, 68 (12): 4500-4505. 10.1158/0008-5472.CAN-08-0041.CrossRefPubMed
30.
go back to reference Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumours. Nature genetics. 2003, 33 (1): 49-54. 10.1038/ng1060.CrossRefPubMed Ramaswamy S, Ross KN, Lander ES, Golub TR: A molecular signature of metastasis in primary solid tumours. Nature genetics. 2003, 33 (1): 49-54. 10.1038/ng1060.CrossRefPubMed
31.
go back to reference van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH: Expression profiling predicts outcome in breast cancer. Breast Cancer Res. 2003, 5 (1): 57-58. 10.1186/bcr562.CrossRefPubMed van 't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH: Expression profiling predicts outcome in breast cancer. Breast Cancer Res. 2003, 5 (1): 57-58. 10.1186/bcr562.CrossRefPubMed
32.
go back to reference Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer cell. 2003, 3 (6): 537-549. 10.1016/S1535-6108(03)00132-6.CrossRefPubMed Kang Y, Siegel PM, Shu W, Drobnjak M, Kakonen SM, Cordon-Cardo C, Guise TA, Massague J: A multigenic program mediating breast cancer metastasis to bone. Cancer cell. 2003, 3 (6): 537-549. 10.1016/S1535-6108(03)00132-6.CrossRefPubMed
33.
go back to reference Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, et al: A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. The EMBO journal. 2002, 21 (8): 1948-1956. 10.1093/emboj/21.8.1948.CrossRefPubMedPubMedCentral Marambaud P, Shioi J, Serban G, Georgakopoulos A, Sarner S, Nagy V, Baki L, Wen P, Efthimiopoulos S, Shao Z, et al: A presenilin-1/gamma-secretase cleavage releases the E-cadherin intracellular domain and regulates disassembly of adherens junctions. The EMBO journal. 2002, 21 (8): 1948-1956. 10.1093/emboj/21.8.1948.CrossRefPubMedPubMedCentral
34.
go back to reference Najy AJ, Day KC, Day ML: The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. The Journal of biological chemistry. 2008, 283 (26): 18393-18401. 10.1074/jbc.M801329200.CrossRefPubMedPubMedCentral Najy AJ, Day KC, Day ML: The ectodomain shedding of E-cadherin by ADAM15 supports ErbB receptor activation. The Journal of biological chemistry. 2008, 283 (26): 18393-18401. 10.1074/jbc.M801329200.CrossRefPubMedPubMedCentral
35.
go back to reference Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Journal of cell science. 2001, 114 (Pt 1): 111-118.PubMed Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. Journal of cell science. 2001, 114 (Pt 1): 111-118.PubMed
36.
go back to reference Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer research. 2006, 66 (23): 11271-11278. 10.1158/0008-5472.CAN-06-2044.CrossRefPubMed Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED: Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2. Cancer research. 2006, 66 (23): 11271-11278. 10.1158/0008-5472.CAN-06-2044.CrossRefPubMed
37.
go back to reference Wells A, Yates C, Shepard CR: E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & experimental metastasis. 2008, 25 (6): 621-628.CrossRef Wells A, Yates C, Shepard CR: E-cadherin as an indicator of mesenchymal to epithelial reverting transitions during the metastatic seeding of disseminated carcinomas. Clinical & experimental metastasis. 2008, 25 (6): 621-628.CrossRef
38.
go back to reference Christofori G: New signals from the invasive front. Nature. 2006, 441 (7092): 444-450. 10.1038/nature04872.CrossRefPubMed Christofori G: New signals from the invasive front. Nature. 2006, 441 (7092): 444-450. 10.1038/nature04872.CrossRefPubMed
39.
go back to reference Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nature reviews. 2002, 2 (8): 563-572. 10.1038/nrc865.PubMed Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nature reviews. 2002, 2 (8): 563-572. 10.1038/nrc865.PubMed
40.
go back to reference Berrier AL, Yamada KM: Cell-matrix adhesion. Journal of cellular physiology. 2007, 213 (3): 565-573. 10.1002/jcp.21237.CrossRefPubMed Berrier AL, Yamada KM: Cell-matrix adhesion. Journal of cellular physiology. 2007, 213 (3): 565-573. 10.1002/jcp.21237.CrossRefPubMed
41.
go back to reference Pankov R, Yamada KM: Fibronectin at a glance. Journal of cell science. 2002, 115 (Pt 20): 3861-3863. 10.1242/jcs.00059.CrossRefPubMed Pankov R, Yamada KM: Fibronectin at a glance. Journal of cell science. 2002, 115 (Pt 20): 3861-3863. 10.1242/jcs.00059.CrossRefPubMed
Metadata
Title
Development of a highly metastatic model that reveals a crucial role of fibronectin in lung cancer cell migration and invasion
Authors
Deshui Jia
Mingxia Yan
Xiaomin Wang
Xiangfang Hao
Linhui Liang
Lei Liu
Hanwei Kong
Xianghuo He
Jinjun Li
Ming Yao
Publication date
01-12-2010
Publisher
BioMed Central
Published in
BMC Cancer / Issue 1/2010
Electronic ISSN: 1471-2407
DOI
https://doi.org/10.1186/1471-2407-10-364

Other articles of this Issue 1/2010

BMC Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine